Atlas Trials

Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.

Clinical trial NCT04577066 · COMPLETED

Trial details

NCT number
NCT04577066
Sponsor
Leiden University Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Plasmodium Falciparum Malaria
Start date
2021-09-27
Primary completion
2022-05-30
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.